SCHEMBL30936192

SCHEMBL30936192

CCc1cc(Nc2ncc(Cl)c(Nc3ccc(OC)cc3NS(C)(=O)=O)n2)c(OC)cc1N1CCC(N2CCN(CCC(=O)Nc3cccc(C4CCC(=O)NC4=O)c3)CC2)CC1

nearest known ligand 0.52

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 18/20 0.52
▸ PTK2 Q05397 2/20 0.45
▸ ALK Q9UM73 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30936935 0.91 EGFR (0.54) EGFRPTK2ALK
SCHEMBL30936291 0.85 EGFR (0.52) EGFRPTK2ALK
SCHEMBL30936784 0.84 EGFR (0.62) EGFRPTK2ALK
SCHEMBL30936837 0.81 EGFR (0.56) EGFRPTK2ALK
SCHEMBL30936294 0.81 EGFR (0.56) EGFRPTK2ALK
SCHEMBL30936283 0.81 EGFR (0.51) EGFRPTK2ALK
SCHEMBL30936776 0.81 EGFR (0.57) EGFRPTK2ALK
SCHEMBL30937108 0.80 EGFR (0.55) EGFRPTK2ALK
SCHEMBL30936763 0.79 EGFR (0.69) EGFR
SCHEMBL26906593 0.79 EGFR (0.69) EGFRALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024072178-A1 COMPOUND FOR TARGETED PROTEIN DEGRADATION, AND USE THEREOF (주)사이러스테라퓨틱스 2024-04-04 — — WO claimed
WO-2024072178-A1 COMPOUND FOR TARGETED PROTEIN DEGRADATION, AND USE THEREOF (주)사이러스테라퓨틱스 2024-04-04 — — WO disclosed
Send feedback